Reply to Skokou, M. Comment on "Keeler et al. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. 2021, , 4158".

Johanna Louise Keeler, Janet Treasure, Mario F Juruena, Carol Kan, Hubertus Himmerich

Journal: Nutrients 2022;14(10):2119

PMID: 35631260

Abstract

In response to our narrative review, which suggested the use of the glutamatergic n-methyl-D-aspartate (NMDA) receptor antagonist ketamine as a potential treatment for anorexia nervosa (AN) [...].

Address: Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK.; South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham BR3 3BX, UK.; Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK.; Eating Disorder Service, Central and North West London NHS Foundation Trust, 1 Nightingale Place, Kensington & Chelsea, London SW10 9NG, UK.

DOI: 10.3390/nu14102119

Link outs

Free resources

Full Text Sources:

MeSH Terms: Anorexia Nervosa, Humans, Ketamine, Nutrients